dc.creator | Araujo, Zaida | |
dc.creator | Giampietro, Francesca | |
dc.creator | Bochichio, Marias de los Angeles | |
dc.creator | Palacios, Andrea | |
dc.creator | Dinis, Jenifer | |
dc.creator | Isern, Jaime | |
dc.creator | De Waard, Jacobus H. | |
dc.creator | Rada, Elsa | |
dc.creator | Borges, Rafael | |
dc.creator | Fernandez de Larrea, Carlos | |
dc.creator | Villasmil, Angel | |
dc.creator | Vanegas, Magnolia | |
dc.creator | Enciso-Moreno, Jose Antonio | |
dc.creator | Patarroyo, Manuel Alfonso | |
dc.date | 2015-12-08T19:41:39Z | |
dc.date | 2015-12-08T19:41:39Z | |
dc.date | 2012-11-07 | |
dc.date.accessioned | 2022-10-28T01:17:28Z | |
dc.date.available | 2022-10-28T01:17:28Z | |
dc.identifier | 1678-8060 | |
dc.identifier | http://hdl.handle.net/10872/13010 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4946701 | |
dc.description | The goal of this study was to demonstrate the usefulness of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of pulmonary tuberculosis (PTB) and extrapulmonary TB (EPTB). This assay used 20 amino acid-long, non-overlapped synthetic peptides that spanned the complete Mycobacterium tuberculosis ESAT-6 and Ag85A sequences. The validation cohort consisted of 1,102 individuals who were grouped into the following five diagnostic groups: 455 patients with PTB, 60 patients with EPTB, 40 individuals with non-EPTB, 33 individuals with leprosy and 514 healthy controls. For the PTB group, two ESAT-6 peptides (12033 and 12034) had the highest sensitivity levels of 96.9% and 96.2%, respectively, and an Ag85A-peptide (29878) was the most specific (97.4%) in the PTB groups. For the EPTB group, two Ag85A peptides (11005 and 11006) were observed to have a sensitivity of 98.3% and an Ag85A-peptide (29878) was also the most specific (96.4%). When combinations of peptides were used, such as 12033 and 12034 or 11005 and 11006, 99.5% and 100% sensitivities in the PTB and EPTB groups were observed, respectively. In conclusion, for a cohort that consists entirely of individuals from Venezuela, a multi-antigen immunoassay using highly sensitive ESAT-6 and Ag85A peptides alone and in combination could be used to more rapidly diagnose PTB and EPTB infection. | |
dc.language | en | |
dc.publisher | Mem Inst Oswaldo Cruz 2013;108(2):131-139 | |
dc.subject | pulmonary tuberculosis | |
dc.subject | extrapulmonary tuberculosis | |
dc.subject | synthetic peptide | |
dc.subject | ESAT-6 antigen | |
dc.subject | Ag85A antigen | |
dc.title | Immunologic evaluation and validation of metods using synthetic peptides derived from Mycobacterium tuberculosis for the diagnosis of tuberculosis infection | |
dc.type | Article | |